Results 171 to 180 of about 7,413 (211)

Epicardial adipose tissue: an overtly concealed contributor to cardiovascular events in chronic kidney disease patients. [PDF]

Lipids Health Dis
Cui L, Yang M.
europepmc   +1 more source

Characterization of residual kidney function in chronic hemodialysis patients using plasma metabolomics. [PDF]

Sci Rep
Jaques DA, Boccard J, Strassel O, Monat MA, Visconti G, Jotterand Drepper V, Marangon N, Saudan P, De Seigneux S, Rudaz S, Ponte B.   +10 more
europepmc   +1 more source

Antibody Screening and Binding Prediction Analysis Targeting Stx2. [PDF]

Antibodies (Basel)
Wu J, Liu C, Peng F, Yu Z, Qiao C, Yang G, Luo H, Sun K, Ning Z, Wang J, Wen Y, Yu J.   +11 more
europepmc   +1 more source

Probiotic Supplementation in Chronic Kidney Disease: Outcomes on Uremic Toxins, Inflammation, and Vascular Calcification from Experimental and Clinical Models. [PDF]

Toxins (Basel)
Obrero T, Pendón-Ruiz de Mier MV, Gordillo-Arnaud JE, Jiménez Moral MJ, Vidal V, Guerrero F, Carmona A, Rodríguez-Ortiz ME, Torralbo AI, Ojeda R, Moyano C, Sanchez-Ramade M, Mesa J, López-Ruiz DJ, Valdés-Díaz K, García-Sáez RM, Jurado-Montoya D, Rodelo-Haad C, Álvarez-Benito M, Glorieux G, Rodríguez M, Soriano-Cabrera S, Muñoz-Castañeda JR.   +22 more
europepmc   +1 more source

Research progress on the intrinsic link between the occurrence and progression of malignant tumors, chronic kidney disease and drug safety. [PDF]

Am J Cancer Res
Zhang D, Jiang S, Liu L, Lu J, Li W.
europepmc   +1 more source

Kinetics of protein-bound uremic toxins in chronic kidney disease

, 2018
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Protein-Bound Uremic Toxins and Immunity

2021
Protein-bound uremic toxins (PBUTs) are bioactive microbiota metabolites originated exclusively from protein fermentation of the bacterial community resident within the gut microbiota, whose composition and function is profoundly different in the chronic kidney disease (CKD) population. PBUTs accumulate in the later stages of CKD because they cannot be
Rocchetti M. T., Cosola C., Ranieri E., Gesualdo L.   +3 more
openaire   +3 more sources

Disposition and clinical implications of protein-bound uremic toxins

Clinical Science, 2017
In patients with chronic kidney disease (CKD), adequate renal clearance is compromised, resulting in the accumulation of a plethora of uremic solutes. These uremic retention solutes, also named uremic toxins, are a heterogeneous group of organic compounds with intrinsic biological activities, many of which are too large to be filtered and/or are ...
Jansen, J., Jankowski, J., Gajjala, P.R., Wetzels, J.F.M., Masereeuw, R.   +4 more
openaire   +5 more sources

Cardiorenal Syndrome: Role of Protein-Bound Uremic Toxins

Journal of Renal Nutrition, 2015
Renal impairment is a strong independent risk factor associated with poor prognosis in cardiovascular disease patients. Renal dysfunction is likely contributed by progressive renal structural damage. Accurate detection of kidney injury in a timely manner as well as increased knowledge of the pathophysiology and mechanisms underlying this injury is of ...
Suree, Lekawanvijit, Henry, Krum
openaire   +2 more sources

PROGRESS IN UREMIC TOXIN RESEARCH: Protein‐Bound Toxins—Update 2009

Seminars in Dialysis, 2009
AbstractProtein‐bound uremic retention solutes constitute a group whose common characteristic is their difficult removal by dialysis. In 2003, the EUTox group described 25 protein‐bound solutes. They comprised six advanced glycation end products (AGE), four phenols (including p‐cresol), six indoles (including indoxylsulfate), two hippurates, three ...
Noémie Jourde‐Chiche, Laetitia Dou, Claire Cerini, Françoise Dignat‐George, Raymond Vanholder, Philippe Brunet   +5 more
openaire   +1 more source